Literature DB >> 3286211

Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.

B Couzinet1, G Schaison.   

Abstract

Entities:  

Keywords:  Abortion, Drug Induced; Abortion, Induced; Animals, Laboratory; Biology; Bleeding; Clinical Research; Contraception; Contraception Research; Diseases; Endocrine System; Endometrial Effects; Endometrium; Family Planning; Fertility Control, Postconception; Genitalia; Genitalia, Female; Hormone Antagonists; Hormones; Human Volunteers; Literature Review; Myometrial Effects; Myometrium; Physiology; Research Methodology; Research Report; Ru-486; Signs And Symptoms; Urogenital System; Uterus; Vacuum Aspiration

Mesh：

Substances：

Year:  1988        PMID： 3286211     DOI： 10.2165/00003495-198835030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  19 in total

1.  Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA.

Authors:  M Misrahi; M Atger; L d'Auriol; H Loosfelt; C Meriel; F Fridlansky; A Guiochon-Mantel; F Galibert; E Milgrom
Journal:  Biochem Biophys Res Commun       Date:  1987-03-13       Impact factor: 3.575

2.  Induction of labour with mifepristone after intrauterine fetal death.

Authors:  D Cabrol; M Bouvier D'Yvoire; E Mermet; L Cedard; C Sureau; E E Baulieu
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

3.  Pituitary and adrenal responses to the anti-progesterone and anti-glucocorticoid steroid RU 486 in primates.

Authors:  D L Healy; G P Chrousos; H M Schulte; R F Williams; P W Gold; E E Baulieu; G D Hodgen
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

4.  Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.

Authors:  D L Healy; E E Baulieu; G D Hodgen
Journal:  Fertil Steril       Date:  1983-08       Impact factor: 7.329

5.  Termination of early pregnancy. Future development.

Authors:  M Bygdeman; N J Christensen; K Gréen; S Zheng; V Lundström
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1983

6.  The progesterone antagonist RU 486. A potential new contraceptive agent.

Authors:  L K Nieman; T M Choate; G P Chrousos; D L Healy; M Morin; D Renquist; G R Merriam; I M Spitz; C W Bardin; E E Baulieu
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

7.  RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.

Authors:  R C Gaillard; A Riondel; A F Muller; W Herrmann; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).

Authors:  B Couzinet; N Le Strat; A Ulmann; E E Baulieu; G Schaison
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

9.  The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

Authors:  K B Horwitz
Journal:  Endocrinology       Date:  1985-06       Impact factor: 4.736

10.  Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women.

Authors:  A Gravanis; G Schaison; M George; J de Brux; P G Satyaswaroop; E E Baulieu; P Robel
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.